Secondary effects observed in immunosuppressive therapy of patients with autoimmune disorders.
D000505:Alopecia / Q000139:chemically induced; D000917:Antibody Formation / Q000187:drug effects; D001324:Autoantigens; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001379:Azathioprine / Q000009:adverse effects; D005334:Fever / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D012166:Retinal Hemorrhage / Q000139:chemically induced
D001324:Autoantigens; D007166:Immunosuppressive Agents; D001379:Azathioprine